Brown Advisory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Brown Advisory's DGX Position: Q2 2026 in Review
Brown Advisory increased its Quest Diagnostics (DGX) stake by 5% in Q2 2026, buying an estimated $69.9K and bringing the position to 7,541 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #779.
Brown Advisory first reported a position in DGX in Q4 2013 and has held it in 43 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Brown Advisory held 7,541 shares of Quest Diagnostics worth $1.6M as of Q2 2026.
- Brown Advisory bought 356 Quest Diagnostics shares in Q2 2026, an estimated $69.9K.
- Quest Diagnostics made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #779 holding.
- Brown Advisory first reported a position in Quest Diagnostics in Q4 2013 and has held it in 43 quarters since.
- 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.